春城熱力(01853.HK)與控股股東春城投資訂立第二份資產轉讓協議
格隆匯11月1日丨春城熱力(01853.HK)公吿,2024年11月1日,公司與公司控股股東春城投資訂立第二份資產轉讓協議,據此,根據第二份資產轉讓協議的條款及條件,公司有條件同意購買,而春城投資有條件同意出售資產,代價為人民幣8288.6萬元。
資產包括春城投資目前用作供熱用途的若干建築物、燃煤鍋爐及配套設備。
由於公司主要從事供熱服務業務且資產用於熱力生產,故公司認為建議收購事項將有助集團進一步提高供熱效率,優化集團供熱業務結構,提高熱源保障能力,大幅減少集團與春城投資集團之間的持續關聯交易程度,並減少集團與春城投資集團之間的潛在競爭,有利於集團的整體戰略發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.